The market for hormones in dosage except contraceptives and antibiotics in Peru experienced fluctuations over the past decade. In 2023, the market stood at $114.03 million. From 2013, it saw significant growth, culminating at $115.02 million in 2021. Although there was a dip in 2018 and 2022, 2023 marked a slight recovery with a 1.99% increase year-on-year. The compound annual growth rate over the last five years was 2.85%, indicating a moderate upward trend despite some volatility in intervening years.

Future trends to watch for include:

Emerging therapeutic applications of hormones driving market demand.
Potential impact of regulatory changes on market dynamics.
Influence of innovations in hormone delivery systems improving market performance.
Shifts in consumer awareness and healthcare practices affecting market growth.